Quarterly report pursuant to Section 13 or 15(d)

LOSS PER SHARE

v3.8.0.1
LOSS PER SHARE
6 Months Ended
Mar. 31, 2018
Earnings Per Share [Abstract]  
LOSS PER SHARE
10. LOSS PER SHARE

  

In accordance with ASC 260-10, basic net income (loss) per share is computed by dividing the net income (loss) to common stockholders for the period by the weighted average number of common shares outstanding during the period. Diluted net income (loss) per share is computed by dividing the net income (loss) for the period by the weighted average number of common and dilutive common equivalent shares outstanding during the period. For the three and six-month periods ended March 31, 2018 and 2017, the Company has excluded all common equivalent shares from the calculation of diluted net loss per share as such securities are anti-dilutive. 

 

A summary of the net income (loss) and shares used to compute net income (loss) per share for the three and six-month periods ended March 31, 2018 and 2017 is as follows: 

 

  Three Months Ended March 31,
  2018   2017
Net loss for computation of basic and diluted net loss per share:      
Net loss $ (2,659,600 )   $ (1,452,000 )
Basic and diluted net loss per share:      
Basic and diluted net loss per share $ (0.61 )   $ (0.61 )
Basic and diluted weighted average shares outstanding 4,362,564     2,372,394  
       
Anti-dilutive common equivalent shares not included in the computation of dilutive net loss per share:      
Warrants 5,617,481     7,032  
Restricted common stock 280,250     143,750  
Options 544,059     334,428  
Total warrants and options 6,451,790     485,210  

 

  Six Months Ended March 31,
  2018   2017
Net loss for computation of basic and diluted net loss per share:      
Net loss $ (5,429,000 )   $ (2,892,200 )
Basic and diluted net loss per share:      
Basic and diluted net loss per share $ (1.25 )   $ (1.29 )
Basic and diluted weighted average shares outstanding 4,347,745     2,236,728  
       
Anti-dilutive common equivalent shares not included in the computation of dilutive net loss per share:      
Warrants 5,617,481     7,093  
Restricted common stock 280,250     143,750  
Options 554,059     329,766  
Total warrants and options 6,451,790     480,609